USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance

Colorectal cancer (CRC) is a highly prevalent malignancy with a poor prognosis. USP20 can support progression of variety of tumors. USP20 was shown to promote breast tumor metastasis, and proliferation of oral squamous carcinoma cells. However, the role of USP20 in CRC remains unclear.We used bioinformatics to analyze the expression and prognosis of USP20 in pan-cancer and explore the relationship between USP20 expression and immune infiltration, immune checkpoints, and chemotherapy resistance in CRC. The differential expression and prognostic role of USP20 in CRC was validated by qRT-PCR and immunohistochemistry. Cox univariate and multivariate analyses were performed to assess risk factors for poor prognosis of CRC, and new prognostic prediction models were constructed and evaluated by decision curve analysis (ROC) and receiver operating characteristic (DCA). USP20 was overexpressed in CRC cell lines to explore the effect of USP20 on the functionalities of CRC cells. Enrichment analyses were used to explore the possible mechanism of USP20 in CRC.The expression of USP20 was lower in CRC tissues than adjacent normal tissues. Compared with low USP20 expression patients, CRC patients with high USP20 expression level had shorter OS. Correlation analysis showed that USP20 expression was associated with lymph node metastasis. Cox regression analysis revealed USP20 as an independent risk factor for poor prognosis in CRC patients. ROC and DCA analyses showed that the performance of the newly constructed prediction model was better than the traditional TNM model. Immune infiltration analysis shown that USP20 expression is closely associated with T cell infiltration in CRC. A co-expression analysis showed that USP20 expression was positively correlated with several immune checkpoint genes including ADORA2A, CD160, CD27 and TNFRSF25 genes and positively associated with multiple multi-drug resistance genes such as MRP1, MRP3, and MRP5 genes. USP20 expression positively correlated with the sensitivity of cells to multiple anticancer drugs. Overexpression of USP20 enhanced the migration and invasive ability of CRC cells. Enrichment pathway analyses showed the USP20 may play a role via the Notch pathway, Hedgehog pathway and beta-catenin pathway.USP20 is downregulated in CRC and associated with prognosis in CRC. USP20 enhances CRC cells metastasis and is associated with immune infiltration, immune checkpoints, and chemotherapy resistance.

[1]  Youxiang Chen,et al.  MiR-22-3p regulates the proliferation, migration and invasion of colorectal cancer cells by directly targeting KDM3A through the Hippo pathway. , 2022, Histology and histopathology.

[2]  Hui-Ying Zhao,et al.  Wnt signaling in colorectal cancer: pathogenic role and therapeutic target , 2022, Molecular cancer.

[3]  A. Jarry,et al.  Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer , 2022, Oncoimmunology.

[4]  Shun Zhang,et al.  SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression , 2022, Canadian journal of gastroenterology & hepatology.

[5]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[6]  Y. Zhang,et al.  USP20 mitigates ischemic stroke in mice by suppressing neuroinflammation and neuron death via regulating PTEN signal. , 2021, International immunopharmacology.

[7]  E. Prochownik,et al.  USP19 exacerbates lipogenesis and colorectal carcinogenesis by stabilizing ME1. , 2021, Cell reports.

[8]  S. Maher,et al.  Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis , 2021, Proceedings of the National Academy of Sciences.

[9]  Y. She,et al.  N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer , 2021, Molecular cancer.

[10]  Wenyi Wei,et al.  SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions , 2021, Molecular Cancer.

[11]  Yunfei Xu,et al.  Hypoxia-induced lncHILAR promotes renal cancer cell invasion and metastasis via ceRNA for the miR-613/206/1-1-3p/Jagged-1/Notch/CXCR4 signaling pathway. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Y. Zhong,et al.  NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer , 2021, Journal of experimental & clinical cancer research : CR.

[13]  M. Fakih,et al.  RAS amplification as a negative predictor of benefit from anti-EGFR containing therapy regimens in metastatic colorectal cancer. , 2021, The oncologist.

[14]  Jie Luo,et al.  Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis , 2020, Nature.

[15]  Yibin Kang,et al.  Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2 , 2020, Genes & development.

[16]  M. Fantini,et al.  Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf , 2020, International journal of molecular sciences.

[17]  L. Terrazas,et al.  Relevance of Regulatory T Cells during Colorectal Cancer Development , 2020, Cancers.

[18]  S. Park,et al.  The Deubiquitinating Enzyme USP20 Regulates the TNFα-Induced NF-κB Signaling Pathway through Stabilization of p62 , 2020, International journal of molecular sciences.

[19]  Yan-Yi Wang,et al.  USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA , 2020, PLoS pathogens.

[20]  F. Brunetti,et al.  Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22). , 2020, Annals of surgery.

[21]  I. Petkovska,et al.  Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy , 2019, JAMA oncology.

[22]  J. Shindoh,et al.  RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases , 2017, Annals of surgery.

[23]  S. Shenoy,et al.  USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Choti,et al.  Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection , 2018, JAMA oncology.

[25]  Z. Lou,et al.  USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization , 2018, Cell Death & Differentiation.

[26]  P. Harms,et al.  Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma. , 2018, Cancer cell.

[27]  M. Scott,et al.  Non-canonical hedgehog pathway activation by MKL1/SRF promotes drug-resistance in basal cell carcinomas , 2018, Nature Medicine.

[28]  H. Kwok,et al.  Abstract 108:In vitroandin vivocharacterization of novel scorpion venom-based peptides for the treatment of colon cancer , 2017 .

[29]  Yingyan Yu,et al.  Deubiquitinating enzyme USP20 is a positive regulator of claspin and suppresses the malignant characteristics of gastric cancer cells , 2017, International journal of oncology.

[30]  H. Ueno,et al.  Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination , 2016, Nature Immunology.

[31]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[32]  Han Liu,et al.  Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner , 2013, Molecular Cancer.

[33]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[34]  K. Kohn,et al.  CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. , 2012, Cancer research.

[35]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[36]  K. Klotz,et al.  Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity , 2011, Cancer Immunology, Immunotherapy.

[37]  A. Ma,et al.  Ubiquitin makes its mark on immune regulation. , 2010, Immunity.

[38]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Messing,et al.  Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. , 2002, Biochemical and biophysical research communications.